Gary Gillheeney | President, Chief Executive Officer & Director |
Henry Hagopian | Interim Chief Financial Officer |
Vik Malhotra | Credit Suisse |
Ryan Zimmerman | BTIG |
Steven Lichtman | Oppenheimer & Company |
Good afternoon, ladies and gentlemen, and welcome to the Third Quarter 2020 Earnings Conference Call for Organogenesis Holdings Inc. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the Company's website for replay shortly.
Before we begin, I would like to remind everyone that our remarks today may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated, including the risks and uncertainties described in the Company's filings with the Securities and Exchange Commission including Item 1A of the Company's most recent annual and quarterly report.
You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made.